Protective effect of qnr on agents other than quinolones that target DNA gyrase

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 11, 2015, Pages 6689-6695

  Jacoby, George A ^a   Corcoran, Marian A ^a   Hooper, David C ^b  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PYRIDONE DERIVATIVE; 8 (3 AMINO 1 PYRROLIDINYL) 1 CYCLOPROPYL 7 FLUORO 9 METHYL 4 OXO 3 QUINOLIZINECARBOXYLIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COUMAMYCIN A1; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) A; GYRAMIDE A; INDOLE DERIVATIVE; MICROCIN B17; NATURAL PRODUCT; NOVOBIOCIN; PROTEIN; PROTEIN QNR; PYRIDONE DERIVATIVE; QUINOLONE DERIVATIVE; SIMOCYCLINONE D8; SPIROPYRIMIDINETRIONE PYRAZINYL ALKYNYL TETRAHYDROQUINOLINE; UNCLASSIFIED DRUG; 3-AMINO-7-(3-(1-AMINOETHYL)PYRROLIDIN-1-YL)-1-CYCLOPROPYL-6-FLUORO-8-METHYL-1H-QUINAZOLINE-2,4-DIONE; AMINOCOUMARIN DERIVATIVE; BACTERIOCIN; COUMAMYCIN; ESCHERICHIA COLI PROTEIN; MICROCIN; PYRROLIDINE DERIVATIVE; QNR PROTEIN, E COLI; QUINAZOLINONE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR PROBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI; GENETICS; METABOLISM;

AMINOCOUMARINS; BACTERIOCINS; DNA GYRASE; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; NOVOBIOCIN; PYRIDONES; PYRROLIDINES; QUINAZOLINONES; QUINOLONES;

EID: 84946238850     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01292-15     Document Type: Article

References (61)

1. Martínez-Martínez L, Pascual A, Jacoby GA. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797-799. http://dx.doi.org/10.1016/S0140-6736(97)07322-4.
2. Drlica K, Hooper DC. 2003. Mechanisms of quinolone action, p 19-40. In Hooper DC, Rubinstein E (ed), Quinolone antimicrobial agents, 3rd ed. ASM Press, Washington, DC.
3. Tran JH, Jacoby GA. 2002. Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci U S A 99:5638-5642. http://dx.doi.org/10.1073/pnas.082092899.
4. Tran JH, Jacoby GA, Hooper DC. 2005. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother 49:118-125. http://dx.doi.org/10.1128/AAC.49.1.118-125.2005.
5. Tran JH, Jacoby GA, Hooper DC. 2005. Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topo-isomerase IV. Antimicrob Agents Chemother 49:3050-3052. http://dx.doi.org/10.1128/AAC.49.7.3050-3052.2005.
6. Poirel L, Liard A, Rodriguez-Martinez JM, Nordmann P. 2005. Vibrionaceae as a possible source of Qnr-like quinolone resistance determinants. J Antimicrob Chemother 56:1118-1121. http://dx.doi.org/10.1093/jac/dki371.
7. Rodríguez-Martínez JM, Velasco C, Briales A, García I, Conejo MC, Pascual A. 2008. Qnr-like pentapeptide repeat proteins in gram-positive bacteria. J Antimicrob Chemother 61:1240-1243. http://dx.doi.org/10.1093/jac/dkn115.
8. Jacoby GA, Hooper DC. 2013. Phylogenetic analysis of chromosomally determined Qnr and related proteins. Antimicrob Agents Chemother 57: 1930-1934. http://dx.doi.org/10.1128/AAC.02080-12.
9. Gellert M, O'Dea MH, Itoh T, Tomizawa J. 1976. Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase. Proc Natl Acad Sci U S A 73:4474-4478. http://dx.doi.org/10.1073/pnas.73.12.4474.
10. Hooper DC, Wolfson JS, McHugh GL, Winters MB, Swartz MN. 1982. Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth. Antimicrob Agents Chemother 22:662-671. http://dx.doi.org/10.1128/AAC.22.4.662.
11. Rajendram M, Hurley KA, Foss MH, Thornton KM, Moore JT, Shaw JT, Weibel DB. 2014. Gyramides prevent bacterial growth by inhibiting DNA gyrase and altering chromosome topology. ACS Chem Biol 9:1312-1319. http://dx.doi.org/10.1021/cb500154m.
12. Parks WM, Bottrill AR, Pierrat OA, Durrant MC, Maxwell A. 2007. The action of the bacterial toxin, microcin B17, on DNA gyrase. Biochimie 89:500-507. http://dx.doi.org/10.1016/j.biochi.2006.12.005.
13. Sissi C, Vazquez E, Chemello A, Mitchenall LA, Maxwell A, Palumbo M. 2010. Mapping simocyclinone D8 interaction with DNA gyrase: evidence for a new binding site on GyrB. Antimicrob Agents Chemother 54:213-220. http://dx.doi.org/10.1128/AAC.00972-09.
14. Hearnshaw SJ, Edwards MJ, Stevenson CE, Lawson DM, Maxwell A. 2014. A new crystal structure of the bifunctional antibiotic simocyclinone D8 bound to DNA gyrase gives fresh insight into the mechanism of inhibition. J Mol Biol 426:2023-2033. http://dx.doi.org/10.1016/j.jmb.2014.02.017.
15. Yoshida H, Bogaki M, Nakamura M, Nakamura S. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother 34:1271-1272. http://dx.doi.org/10.1128/AAC.34.6.1271.
16. Vetting MW, Hegde SS, Wang M, Jacoby GA, Hooper DC, Blanchard JS. 2011. Structure of QnrB1, a plasmid-mediated fluoroquinolone resistance factor. J Biol Chem 286:25265-25273. http://dx.doi.org/10.1074/jbc.M111.226936.
17. CLSI. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 9th ed. CLSI document M07-A9. CLSI, Wayne, PA.
18. Gillies RR, Govan JR. 1966. Typing of Pseudomonas pyocyanea by pyocine production. J Pathol Bacteriol 91:339-345. http://dx.doi.org/10.1002/path.1700910207.
19. Flamm RK, Vojtko C, Chu DT, Li Q, Beyer J, Hensey D, Ramer N, Clement JJ, Tanaka SK. 1995. In vitro evaluation of ABT-719, a novel DNA gyrase inhibitor. Antimicrob Agents Chemother 39:964-970. http://dx.doi.org/10.1128/AAC.39.4.964.
20. Alder J, Clement J, Meulbroek J, Shipkowitz N, Mitten M, Jarvis K, Oleksijew A, Hutch T, Sr, Paige L, Flamm B. 1995. Efficacies of ABT-719 and related 2-pyridones, members of a new class of antibacterial agents, against experimental bacterial infections. Antimicrob Agents Chemother 39:971-975. http://dx.doi.org/10.1128/AAC.39.4.971.
21. Huband MD, Cohen MA, Zurack M, Hanna DL, Skerlos LA, Sulavik MC, Gibson GW, Gage JW, Ellsworth E, Stier MA, Gracheck SJ. 2007. In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups. Antimicrob Agents Chemother 51:1191-1201. http://dx.doi.org/10.1128/AAC.01321-06.
22. Pan XS, Gould KA, Fisher LM. 2009. Probing the differential interactions of quinazolinedione PD 0305970 and quinolones with gyrase and topoisomerase IV. Antimicrob Agents Chemother 53:3822-3831. http://dx.doi.org/10.1128/AAC.00113-09.
23. Kern G, Basarab GS, Andrews B, Schuck V, Stone G, Kutschke A, Beaudoin M-E, San Martin M, Brassil P, Fan JH, Mills SD, Doig P. 2011. A DNA gyrase inhibitor with a novel mode of inhibition and in vivo efficacy, abstr F1-1840. Abstr 51st Intersci Conf Antimicrob Agents Chemother.
24. Tari LW, Li X, Trzoss M, Bensen DC, Chen Z, Lam T, Zhang J, Lee SJ, Hough G, Phillipson D, Akers-Rodriguez S, Cunningham ML, Kwan BP, Nelson KJ, Castellano A, Locke JB, Brown-Driver V, Murphy TM, Ong VS, Pillar CM, Shinabarger DL, Nix J, Lightstone FC, Wong SE, Nguyen TB, Shaw KJ, Finn J. 2013. Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents. PLoS One 8:e84409. http://dx.doi.org/10.1371/journal.pone.0084409.
25. Zhang J, Cross J, Yang Q, Mesleh M, Romero J, Wang B, Bevan D, Hall K, Epie F, Moy T, Daniel A, Shotwell J, Chamberlain B, Carter N, Ryan D, Metcalf C, Silverman J, Nguyen K, Lippa B, Dolle R. 2013. The discovery of pyrazolopyridones as a novel class of gyrase B inhibitors through fragment- and structure-based drug discovery, abstr F-1224. Abstr 53rd Intersci Conf Antimicrob Agents Chemother.
26. Edwards MJ, Flatman RH, Mitchenall LA, Stevenson CE, Le TB, Clarke TA, McKay AR, Fiedler HP, Buttner MJ, Lawson DM, Maxwell A. 2009. A crystal structure of the bifunctional antibiotic simocyclinone D8, bound to DNA gyrase. Science 326:1415-1418. http://dx.doi.org/10.1126/science.1179123.
27. Jacoby GA, Walsh KE, Mills DM, Walker VJ, Oh H, Robicsek A, Hooper DC. 2006. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob Agents Chemother 50:1178-1182. http://dx.doi.org/10.1128/AAC.50.4.1178-1182.2006.
28. Martínez-Martínez L, Pascual A, García I, Tran J, Jacoby GA. 2003. Interaction of plasmid and host quinolone resistance. J Antimicrob Chemother 51:1037-1039. http://dx.doi.org/10.1093/jac/dkg157.
29. Wang M, Sahm DF, Jacoby GA, Zhang Y, Hooper DC. 2004. Activities of newer quinolones against Escherichia coli and Klebsiella pneumoniae containing the plasmid-mediated quinolone resistance determinant qnr. Antimicrob Agents Chemother 48:1400-1401. http://dx.doi.org/10.1128/AAC.48.4.1400-1401.2004.
30. Laponogov I, Pan XS, Veselkov DA, McAuley KE, Fisher LM, Sanderson MR. 2010. Structural basis of gate-DNA breakage and resealing by type II topoisomerases. PLoS One 5:e11338. http://dx.doi.org/10.1371/journal.pone.0011338.
31. Aldred KJ, Kerns RJ, Osheroff N. 2014. Mechanism of quinolone action and resistance. Biochemistry 53:1565-1574. http://dx.doi.org/10.1021/bi5000564.
32. Hooper DC. 2003. Mechanisms of quinolone resistance, p 41-67. In Hooper DC, Rubinstein E (ed), Quinolone antimicrobial agents, 3rd ed. ASM Press, Washington, DC.
33. Kim ES, Chen C, Braun M, Kim HY, Okumura R, Wang Y, Jacoby GA, Hooper DC. 22 June 2015. Interactions between QnrB, QnrB mutants, and DNA gyrase. Antimicrob Agents Chemother http://dx.doi.org/10.1128/AAC.00771-15.
34. Gross CH, Parsons JD, Grossman TH, Charifson PS, Bellon S, Jernee J, Dwyer M, Chambers SP, Markland W, Botfield M, Raybuck SA. 2003. Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysistoDNA supercoiling and amino acid substitutions leading to novobiocin resistance. Antimicrob Agents Chemother 47:1037-1046. http://dx.doi.org/10.1128/AAC.47.3.1037-1046.2003.
35. Fujimoto-Nakamura M, Ito H, Oyamada Y, Nishino T, Yamagishi J. 2005. Accumulation of mutations in both gyrB and parE genes is associated with high-level resistance to novobiocin in Staphylococcus aureus. Antimicrob Agents Chemother 49:3810-3815. http://dx.doi.org/10.1128/AAC.49.9.3810-3815.2005.
36. Aldred KJ, McPherson SA, Wang P, Kerns RJ, Graves DE, Turnbough CL, Jr, Osheroff N. 2012. Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance. Biochemistry 51:370-381. http://dx.doi.org/10.1021/bi2013905.
37. Kwak YG, Jacoby GA, Hooper DC. 2015. Effect of Qnr on plasmid gyrase toxins CcdB and ParE. Antimicrob Agents Chemother 59:5078-5079. http://dx.doi.org/10.1128/AAC.00524-15.
38. Dao-Thi MH, Van Melderen L, De Genst E, Afif H, Buts L, Wyns L, Loris R. 2005. Molecular basis of gyrase poisoning by the addiction toxin CcdB. J Mol Biol 348:1091-1102. http://dx.doi.org/10.1016/j.jmb.2005.03.049.
39. Smith AB, Maxwell A. 2006. A strand-passage conformation of DNA gyrase is required to allow the bacterial toxin, CcdB, to access its binding site. Nucleic Acids Res 34:4667-4676. http://dx.doi.org/10.1093/nar/gkl636.
40. Mt and QnrB4 exhibit opposite effects on DNA gyrase catalytic reactions and on the ternary gyrase-DNA-quinolone complex. J Bacteriol 191:1587-1594. http://dx.doi.org/10.1128/JB.01205-08.
41. Hashimi SM, Wall MK, Smith AB, Maxwell A, Birch RG. 2007. The phytotoxin albicidin is a novel inhibitor of DNA gyrase. Antimicrob Agents Chemother 51:181-187. http://dx.doi.org/10.1128/AAC.00918-06.
42. Cociancich S, Pesic A, Petras D, Uhlmann S, Kretz J, Schubert V, Vieweg L, Duplan S, Marguerettaz M, Noell J, Pieretti I, Hugelland M, Kemper S, Mainz A, Rott P, Royer M, Sussmuth RD. 19 January 2015. The gyrase inhibitor albicidin consists of p-aminobenzoic acids and cyanoalanine. Nat Chem Biol http://dx.doi.org/10.1038/nchembio.1734.
43. McCullough JE, Muller MT, Howells AJ, Maxwell A, O'Sullivan J, Summerill RS, Parker WL, Wells JS, Bonner DP, Fernandes PB. 1993. Clerocidin, a terpenoid antibiotic, inhibits bacterial DNA gyrase. J Antibiot (Tokyo) 46:526-530. http://dx.doi.org/10.7164/antibiotics.46.526.
44. Pan XS, Dias M, Palumbo M, Fisher LM. 2008. Clerocidin selectively modifies the gyrase-DNA gate to induce irreversible and reversible DNA damage. Nucleic Acids Res 36:5516-5529. http://dx.doi.org/10.1093/nar/gkn539.
45. Baumann S, Herrmann J, Raju R, Steinmetz H, Mohr KI, Huttel S, Harmrolfs K, Stadler M, Muller R. 2014. Cystobactamids: myxobacterial topoisomerase inhibitors exhibiting potent antibacterial activity. Angew Chem Int Ed Engl 53:14605-14609. http://dx.doi.org/10.1002/anie.201409964.
46. Jacoby GA, Han P. 1996. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 34:908-911.
47. Whitney EN. 1971. The tolC locus in Escherichia coli K12. Genetics 67:39-53.
48. Garrido MC, Herrero M, Kolter R, Moreno F. 1988. The export of the DNA replication inhibitor Microcin B17 provides immunity for the host cell. EMBO J 7:1853-1862.
49. Gay K, Robicsek A, Strahilevitz J, Park CH, Jacoby G, Barrett TJ, Medalla F, Chiller TM, Hooper DC. 2006. Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin Infect Dis 43:297-304. http://dx.doi.org/10.1086/505397.
50. Bernard P, Couturier M. 1992. Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes. J Mol Biol 226: 735-745. http://dx.doi.org/10.1016/0022-2836(92)90629-X.
51. Contreras A, Maxwell A. 1992. gyrB mutations which confer coumarin resistance also affect DNA supercoiling and ATP hydrolysis by Escherichia coli DNA gyrase. Mol Microbiol 6:1617-1624. http://dx.doi.org/10.1111/j.1365-2958.1992.tb00886.x.
52. Fournier B, Hooper DC. 1998. Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effectsonquinolone and coumarin activity. Antimicrob Agents Chemother 42:121-128. http://dx.doi.org/10.1093/jac/42.1.121.
53. Foss MH, Hurley KA, Sorto N, Lackner LL, Thornton KM, Shaw JT, Weibel DB. 2011. N-Benzyl-3-sulfonamidopyrrolidines are a new class of bacterial DNA gyrase inhibitors. ACS Med Chem Lett 2:289-292. http://dx.doi.org/10.1021/ml1002822.
54. Vizán JL, Hernández-Chico C, del Castillo I, Moreno F. 1991. The peptide antibiotic microcin B17 induces double-strand cleavage of DNA mediated by E. coli DNA gyrase. EMBO J 10:467-476.
55. Heddle JG, Blance SJ, Zamble DB, Hollfelder F, Miller DA, Wentzell LM, Walsh CT, Maxwell A. 2001. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition. J Mol Biol 307: 1223-1234. http://dx.doi.org/10.1006/jmbi.2001.4562.
56. Jiang Y, Pogliano J, Helinski DR, Konieczny I. 2002. ParE toxin encoded by the broad-host-range plasmid RK2 is an inhibitor of Escherichia coli gyrase. Mol Microbiol 44:971-979. http://dx.doi.org/10.1046/j.1365-2958.2002.02921.x.
57. Schimana J, Fiedler HP, Groth I, Sussmuth R, Beil W, Walker M, Zeeck A. 2000. Simocyclinones, novel cytostatic angucyclinone antibiotics produced by Streptomyces antibioticus Tu 6040. I. Taxonomy, fermentation, isolation and biological activities. J Antibiot (Tokyo) 53:779-787.
58. Oppegard LM, Hamann BL, Streck KR, Ellis KC, Fiedler HP, Khodursky AB, Hiasa H. 2009. In vivo and in vitro patterns of the activity of simocyclinone D8, an angucyclinone antibiotic from Streptomyces antibioticus. Antimicrob Agents Chemother 53:2110-2119. http://dx.doi.org/10.1128/AAC.01440-08.
59. Flatman RH, Howells AJ, Heide L, Fiedler HP, Maxwell A. 2005. Simocyclinone D8, an inhibitor of DNA gyrase with a novel mode of action. Antimicrob Agents Chemother 49:1093-1100. http://dx.doi.org/10.1128/AAC.49.3.1093-1100.2005.
60. Miller AA, Bundy GL, Mott JE, Skepner JE, Boyle TP, Harris DW, Hromockyj AE, Marotti KR, Zurenko GE, Munzner JB, Sweeney MT, Bammert GF, Hamel JC, Ford CW, Zhong WZ, Graber DR, Martin GE, Han F, Dolak LA, Seest EP, Ruble JC, Kamilar GM, Palmer JR, Banitt LS, Hurd AR, Barbachyn MR. 2008. Discovery and characterization of QPT-1, the progenitorofanew class ofbacterial topoisomerase inhibitors. Antimicrob Agents Chemother 52:2806-2812. http://dx.doi.org/10.1128/AAC.00247-08.
61. Basarab GS, Brassil P, Doig P, Galullo V, Haimes HB, Kern G, Kutschke A, McNulty J, Schuck VJ, Stone G, Gowravaram M. 2014. Novel DNA gyrase inhibiting spiropyrimidinetriones with a benzisoxazole scaffold: SAR and in vivo characterization. J Med Chem 57:9078-9095. http://dx.doi.org/10.1021/jm501174m.